Charles River Laboratories International, Inc. News Headlines

CRL 
$62.81
*  
1.66
2.57%
Get CRL Alerts
*Delayed - data as of Oct. 30, 2014  -  Find a broker to begin trading CRL now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong
10/30/2014 8:11:00 PM - TheStreet


Charles River (CRL) Beats on Q3 Earnings, Guidance Upped - Analyst Blog
10/30/2014 12:30:00 PM - Zacks.com


Charles River Laboratories Q3 14 Earnings Conference Call At 9:00 AM ET
10/30/2014 8:00:00 AM - RTT News


Charles River Laboratories Q3 Profit Rises, Lifts Outlook
10/29/2014 7:57:00 PM - RTT News


Earnings Reaction History: Charles River Laboratories, 100.0% Follow-Through Indicator, 2.5% Sensitive
10/29/2014 3:03:54 PM - MT Newswires


Express Scripts Reports In-Line Q3 Earnings, Narrows View - Analyst Blog
10/29/2014 2:26:00 PM - Zacks.com


McKesson Beats on Q2 Earnings, Revenues; Keeps Guidance - Analyst Blog
10/29/2014 11:14:00 AM - Zacks.com


Will Cigna's (CI) Business Diversity Drive Q3 Earnings Beat? - Analyst Blog
10/28/2014 6:01:00 PM - Zacks.com


Will PerkinElmer (PKI) Disappoint This Earnings Season? - Analyst Blog
10/28/2014 5:59:00 PM - Zacks.com


Why Earnings Season Could Be Great for Charles River Laboratories International (CRL) - Tale of the Tape
10/28/2014 8:57:00 AM - Zacks.com


Why Charles River Laboratories International (CRL) Could Beat Earnings Estimates Again - Tale of the Tape
10/28/2014 8:52:00 AM - Zacks.com


Will WellPoint (WLP) Surpass Q3 Earnings Estimates? - Analyst Blog
10/27/2014 3:00:00 PM - Zacks.com


Omnicare Beats on Q3 Earnings and Sales, Outlook Positive - Analyst Blog
10/27/2014 12:40:00 PM - Zacks.com


Healthways Earnings and Revenues in Line, View Maintained - Analyst Blog
10/24/2014 10:10:00 AM - Zacks.com


Dynavax Initiates Phase I/II Trial on Lymphoma Candidate - Analyst Blog
10/14/2014 4:35:00 PM - Zacks.com


Progenics/Salix's Relistor Label Expanded in the U.S. - Analyst Blog
10/2/2014 5:20:00 PM - Zacks.com


Alimera/pSivida's Iluvien Receives FDA Approval for DME - Analyst Blog
9/29/2014 5:55:00 PM - Zacks.com


Dynavax (DVAX) Completes Enrolment for Study on Heplisav - Analyst Blog
9/23/2014 5:00:00 PM - Zacks.com


Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog
9/19/2014 6:10:00 PM - Zacks.com


Charles River (CRL) Stock: Moving Average Crossover Alert - Tale of the Tape
9/9/2014 10:07:38 AM - Zacks.com


Charles River To Present At  Morgan Stanley Conference; Webcast At 10:00 AM ET
9/9/2014 9:01:00 AM - RTT News


iKang Healthcare Group, Inc. (KANG) Jumps: Stock Surges 10.1% - Tale of the Tape
8/26/2014 9:11:00 AM - Zacks.com


Update: Charles River Labs Earnings
8/20/2014 1:40:00 PM - Seeking Alpha


Novo Nordisk to Pay Fine, Tresiba in Focus - Analyst Blog
8/19/2014 5:50:00 PM - Zacks.com


Why Charles River Laboratories International (CRL) Could Beat Earnings Estimates Again - Tale of the Tape
8/18/2014 8:49:00 AM - Zacks.com